Pearle Vision announces 2013 expansion

Article

Ernie Bowling, OD, reports on retail outlet Pearle Vision’s plans for expansion this year, during the 90th annual SECO International meeting in Atlanta.

Chief Optometric Editor Ernie Bowling, OD, reports on retail outlet Pearle Vision’s plans for expansion this year, during the 90th annual SECO International meeting in Atlanta:

Pearle Vision, North America’s largest licensed optical brand, outlined its 2013 expansion plans. Tammy Reaves, vice president of licensing and development for Pearle Vision, said the company intends to convert 35 corporate locations to franchise opportunities in addition to building up to 10 new stores this year.

The company has identified Florida, Ohio, and Michigan as the first markets for its re-licensing efforts. Specifically in Florida, Pearle is looking to convert corporate locations in Miami, West Palm Beach, Naples, Jacksonville, and Orlando to licensed locations. In Ohio, the company intends to convert locations in Cleveland, Columbus, and Cincinnati. Michigan centers in Detroit, Grand Rapids, Lansing, and Flint are available.

“We are looking for doctors who desire to work with a proven brand and provide superior eyecare and patient service,” Reaves said.

Pearle Vision is built around a doctor-centered business model and is owned by eyewear manufacturer and distributor Luxottica.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.